MEDP vs RVTY: fair value comparison
Medpace Holdings, Inc. and Revvity, Inc. · Updated 2026-08-31
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, MEDP currently sits closer to the top of our discount ranking. RVTY carries the stronger quality grade.
| MEDP | RVTY | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $573.29 | $128.80 |
| 12-month range | $417.54–$594.02 | $86.68–$115.22 |
| Sector rank | #90 of 113 Healthcare | #91 of 113 Healthcare |
| Quality grade | C | A |
| Momentum grade | — | B |
| Leverage | Low | Low |
| Margin trend | — | Contracting |
| Revenue growth | — | Modest |
| RSI zone | Neutral | Overbought |
| 50/200-day trend | Mixed | — |
| DCF cross-check | — | Overvalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: MEDP fair value analysis · RVTY fair value analysis